These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 28965572

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Sodium Selenite Decreased HDAC Activity, Cell Proliferation and Induced Apoptosis in Three Human Glioblastoma Cells.
    Hazane-Puch F, Arnaud J, Trocmé C, Faure P, Laporte F, Champelovier P.
    Anticancer Agents Med Chem; 2016; 16(4):490-500. PubMed ID: 26286659
    [Abstract] [Full Text] [Related]

  • 3. Temozolomide resistance mechanisms: unveiling the role of translesion DNA polymerase kappa in glioblastoma spheroids in vitro.
    Ribeiro DL, Latancia MT, de Souza I, Ariwoola AA, Mendes D, Rocha CRR, Lengert AVH, Menck CFM.
    Biosci Rep; 2024 May 29; 44(5):. PubMed ID: 38717250
    [Abstract] [Full Text] [Related]

  • 4. A New Patient-Derived Metastatic Glioblastoma Cell Line: Characterisation and Response to Sodium Selenite Anticancer Agent.
    Berthier S, Larrouquère L, Champelovier P, Col E, Lefebvre C, Cottet-Rouselle C, Arnaud J, Garrel C, Laporte F, Boutonnat J, Faure P, Hazane-Puch F.
    Cancers (Basel); 2018 Dec 21; 11(1):. PubMed ID: 30583471
    [Abstract] [Full Text] [Related]

  • 5. YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell line.
    Akiyama Y, Ashizawa T, Komiyama M, Miyata H, Oshita C, Omiya M, Iizuka A, Kume A, Sugino T, Hayashi N, Mitsuya K, Nakasu Y, Yamaguchi K.
    Oncol Rep; 2014 Jul 21; 32(1):159-66. PubMed ID: 24842123
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of carbonic anhydrase IX in glioblastoma multiforme.
    Amiri A, Le PU, Moquin A, Machkalyan G, Petrecca K, Gillard JW, Yoganathan N, Maysinger D.
    Eur J Pharm Biopharm; 2016 Dec 21; 109():81-92. PubMed ID: 27702686
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Transcriptional CDK inhibitors, CYC065 and THZ1 promote Bim-dependent apoptosis in primary and recurrent GBM through cell cycle arrest and Mcl-1 downregulation.
    Juric V, Hudson L, Fay J, Richards CE, Jahns H, Verreault M, Bielle F, Idbaih A, Lamfers MLM, Hopkins AM, Rehm M, Murphy BM.
    Cell Death Dis; 2021 Aug 03; 12(8):763. PubMed ID: 34344865
    [Abstract] [Full Text] [Related]

  • 12. Resveratrol reverses temozolomide resistance by downregulation of MGMT in T98G glioblastoma cells by the NF-κB-dependent pathway.
    Huang H, Lin H, Zhang X, Li J.
    Oncol Rep; 2012 Jun 03; 27(6):2050-6. PubMed ID: 22426504
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of GSH synthesis potentiates temozolomide-induced bystander effect in glioblastoma.
    Kohsaka S, Takahashi K, Wang L, Tanino M, Kimura T, Nishihara H, Tanaka S.
    Cancer Lett; 2013 Apr 30; 331(1):68-75. PubMed ID: 23246370
    [Abstract] [Full Text] [Related]

  • 14. Combined treatment with 2'-hydroxycinnamaldehyde and temozolomide suppresses glioblastoma tumorspheres by decreasing stemness and invasiveness.
    Jeong H, Park J, Shim JK, Lee JE, Kim NH, Kim HS, Chang JH, Yook JI, Kang SG.
    J Neurooncol; 2019 May 30; 143(1):69-77. PubMed ID: 30887242
    [Abstract] [Full Text] [Related]

  • 15. Histone deacetylase inhibitors exert anti-tumor effects on human adherent and stem-like glioma cells.
    Was H, Krol SK, Rotili D, Mai A, Wojtas B, Kaminska B, Maleszewska M.
    Clin Epigenetics; 2019 Jan 17; 11(1):11. PubMed ID: 30654849
    [Abstract] [Full Text] [Related]

  • 16. Analysis of the safety of mesenchymal stromal cells secretome for glioblastoma treatment.
    Onzi GR, Ledur PF, Hainzenreder LD, Bertoni AP, Silva AO, Lenz G, Wink MR.
    Cytotherapy; 2016 Jul 17; 18(7):828-37. PubMed ID: 27210718
    [Abstract] [Full Text] [Related]

  • 17. Combination Therapy with AKT3 and PI3KCA siRNA Enhances the Antitumor Effect of Temozolomide and Carmustine in T98G Glioblastoma Multiforme Cells.
    Paul-Samojedny M, Pudełko A, Kowalczyk M, Fila-Daniłow A, Suchanek-Raif R, Borkowska P, Kowalski J.
    BioDrugs; 2016 Apr 17; 30(2):129-44. PubMed ID: 26902608
    [Abstract] [Full Text] [Related]

  • 18. Bioengineered 3D brain tumor model to elucidate the effects of matrix stiffness on glioblastoma cell behavior using PEG-based hydrogels.
    Wang C, Tong X, Yang F.
    Mol Pharm; 2014 Jul 07; 11(7):2115-25. PubMed ID: 24712441
    [Abstract] [Full Text] [Related]

  • 19. Temozolomide induces apoptosis and senescence in glioma cells cultured as multicellular spheroids.
    Günther W, Pawlak E, Damasceno R, Arnold H, Terzis AJ.
    Br J Cancer; 2003 Feb 10; 88(3):463-9. PubMed ID: 12569392
    [Abstract] [Full Text] [Related]

  • 20. APE1/REF-1 down-regulation enhances the cytotoxic effects of temozolomide in a resistant glioblastoma cell line.
    Montaldi AP, Godoy PR, Sakamoto-Hojo ET.
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov 10; 793():19-29. PubMed ID: 26520369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.